BBVA
UTHR icon

Banco Bilbao Vizcaya Argentaria’s United Therapeutics UTHR Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-610
Closed -$357K – 770
2026
Q1 		$357K Hold
610
– – ﹤0.01% 671
2025
Q4 		$302K Buy
+610
New +$284K ﹤0.01% 664

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Banco Bilbao Vizcaya Argentaria's UTHR Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 610 shares — an estimated $357K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in UTHR in Q4 2025 and held it in 2 quarters. The position peaked at $357K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 610 United Therapeutics shares in Q2 2026, an estimated $357K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in United Therapeutics in Q4 2025 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's United Therapeutics position peaked at $357K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.